Relay Therapeutics (RLAY)
(Delayed Data from NSDQ)
$6.58 USD
+0.17 (2.65%)
Updated Oct 10, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Relay Therapeutics, Inc. (RLAY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$21.50 | $29.00 | $16.00 | 226.75% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Relay Therapeutics, Inc. comes to $21.50. The forecasts range from a low of $16.00 to a high of $29.00. The average price target represents an increase of 226.75% from the last closing price of $6.58.
Analyst Price Targets (12)
Broker Rating
Relay Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.15 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.15 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, 12 are Strong Buy, representing 92.31% of all recommendations. A month ago, Strong Buy represented 92.31%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 11 | 11 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.15 | 1.15 | 1.15 | 1.17 | 1.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/16/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
9/10/2024 | Goldman Sachs | Salveen Richter | Not Available | Strong Buy |
9/10/2024 | Not Identified | Not Identified | Hold | Strong Buy |
9/10/2024 | Not Identified | Not Identified | Hold | Hold |
9/9/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/24/2024 | SVB Securities | Andrew Berens | Strong Buy | Strong Buy |
7/18/2024 | JMP Securities | Silvan C Tuerkcan | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Yaron Werber | Strong Buy | Strong Buy |
2/22/2024 | Guggenheim Securities | Michael Schmidt | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.15 |
ABR (Last week) | 1.15 |
# of Recs in ABR | 13 |
Average Target Price | $21.50 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 99 of 252 |
Current Quarter EPS Est: | -0.77 |
RLAY FAQs
Relay Therapeutics, Inc. (RLAY) currently has an average brokerage recommendation (ABR) of 1.15 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for Relay Therapeutics, Inc. (RLAY) is $21.50. The current on short-term price targets is based on 9 reports.
The forecasts for Relay Therapeutics, Inc. (RLAY) range from a low of $16 to a high of $29. The average price target represents a increase of $226.75 from the last closing price of $6.58.
The current UPSIDE for Relay Therapeutics, Inc. (RLAY) is 226.75%
Based on short-term price targets offered by 12 analysts, the average price target for Relay Therapeutics, Inc. comes to $21.50. The forecasts range from a low of $16.00 to a high of $29.00. The average price target represents an increase of 226.75% from the last closing price of $6.58.